Cite
Gaston CL, Grimer RJ, Parry M, et al. Current status and unanswered questions on the use of Denosumab in giant cell tumor of bone. Clin Sarcoma Res. 2016;6(1):15doi: 10.1186/s13569-016-0056-0.
Gaston, C. L., Grimer, R. J., Parry, M., Stacchiotti, S., Dei Tos, A. P., Gelderblom, H., Ferrari, S., Baldi, G. G., Jones, R. L., Chawla, S., Casali, P., LeCesne, A., Blay, J. Y., Dijkstra, S. P., Thomas, D. M., & Rutkowski, P. (2016). Current status and unanswered questions on the use of Denosumab in giant cell tumor of bone. Clinical sarcoma research, 6(1), 15. https://doi.org/10.1186/s13569-016-0056-0
Gaston, Czar Louie, et al. "Current status and unanswered questions on the use of Denosumab in giant cell tumor of bone." Clinical sarcoma research vol. 6,1 (2016): 15. doi: https://doi.org/10.1186/s13569-016-0056-0
Gaston CL, Grimer RJ, Parry M, Stacchiotti S, Dei Tos AP, Gelderblom H, Ferrari S, Baldi GG, Jones RL, Chawla S, Casali P, LeCesne A, Blay JY, Dijkstra SP, Thomas DM, Rutkowski P. Current status and unanswered questions on the use of Denosumab in giant cell tumor of bone. Clin Sarcoma Res. 2016 Sep 14;6(1):15. doi: 10.1186/s13569-016-0056-0. eCollection 2016. PMID: 27651889; PMCID: PMC5022265.
Copy
Download .nbib